Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
Saved in:
| Title: | Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. |
|---|---|
| Authors: | Apfel SC (AUTHOR), Schwartz S (AUTHOR), Adornato BT (AUTHOR), Freeman R (AUTHOR), Biton V (AUTHOR), Rendell M (AUTHOR), Vinik A (AUTHOR), Giuliani M (AUTHOR), Stevens JC (AUTHOR), Barbano R (AUTHOR), Dyck PJ (AUTHOR), rhNGF Clinical Investigator Group (CORPORATE AUTHOR), Apfel, S C1 (AUTHOR), Schwartz, S (AUTHOR), Adornato, B T (AUTHOR), Freeman, R (AUTHOR), Biton, V (AUTHOR), Rendell, M (AUTHOR), Vinik, A (AUTHOR), Giuliani, M (AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 11/1/2000, Vol. 284 Issue 17, p2215-2221. 7p. |
| URL: | 3716807 |
| Database: | Academic Search Ultimate |
| ISSN: | 00987484 |
|---|---|
| DOI: | 10.1001/jama.284.17.2215 |
